Wednesday, October 7, 2009

Wheeze Detector for Quantifying Asthma, Allergy, Emphysema Symptoms

Filed under: Medicine , Pediatrics

Israel's business newspaper Globes is reporting that KarmelSonix Ltd, a company consisting of Israel's KarmelSonix and Australia's Pulmosonix, received FDA approval for the Wheezometer point-of-care wheeze detector. The device records thirty seconds of breathing while applied to the neck area and analyzes and quantifies the wheezing in the audio.

The WheezoMeter™ is calibrated and validated as determined by consensus of a panel of experts who evaluated and scored many recordings for presence of wheeze.

The WheezoMeter™ uses a cascade of 6 proprietary technologies to "defend" the signals against false detection of ambient noises as wheeze.

Obtain a “spot check” measurement of present wheeze activity, any time, any place, as often as needed without any patient effort.

Measure WheezeRATE™ before and after administration of a bronchodilator (“pre-post” test).

Communicate status of homebound or remote patient to physician or healthcare professional.

System Components:

WheezoMeter™ with embedded Black Fin® processor. Self-contained cushioned built-in silicone-coated PPG

PPG Sensor with broad spectrum frequency response, >60 dB dynamic range and superior ambient noise rejection

Allows scrolling of the last 10 measurements for review

2 AA batteries (not included)

Infant sensor holder for babies and toddlers (optional)

More from Globes: FDA approves KarmelSonix's Wheezometer

Product page: Wheezometer

Wheezometer brochure...

                (0)

Name:


Email Address
(will not be published):


URL:

Remember personal info?
(anonymous comments allowed)

Yes No

Comments:

Verification (needed to reduce spam):

Click the "Post" button only once!